Glucagon-like peptide-1 (GLP-1), which is secreted from gut cells and hindbrain areas, has been studied in metabolic diseases such as obesity and diabetes, and was shown to control glucose metabolism and insulin resistance. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.